semaglutide fda submission Clears For Cardiac Risk Reduction in Diabetic Patients FDA Accepts NDA Submission for

Orforgliprion caused an average 11% weight loss among overweight and obese people after a year and a half, researchers reported in the New England Journal of Medicine

C-peptide for Type 2 Diabetes: In contrast, Type 2 diabetes patients typically have normal or increased levels of C-peptide, which reflects insulin resistance rather than a lack of insulin production

Fibromyalgia Fibromyalgia is a condition where central pain sensitization, rather than peripheral inflammation, drives the symptom picture

Rather than taking a high dose once in a while, your body responds better to a consistent, daily supply that keeps your internal "stores" topped up

A scoping review of Pacing for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Lessons learned for the long COVID pandemic

Taylor Zentz (27:15) What would you recommend to a consumer to look for when choosing a glutathione supplement